Insight Medical publishing handpicks the article for publication after a thorough and careful scrutiny following single blind peer reviewing. The articles generally deploy quantitative method to explore a particular topic or theme with empirical evidence. Review articles written based on the secondary data unearth important dimensions of the topic that is otherwise hidden. There are commentaries, reflecting the individual viewpoints and case reports that pay an exclusive focus on a particular aspect of the scientific development. Our journals are always open to novice practices and we encourage the manuscripts that document the ongoing changes and the latest advancements in the field concerned.
Author(s): Andrey Pimenov
Journal of Environmental ResearchAuthor(s): Keiko Hattori, Junko Shimizu, Michiko Koyam
Journal of Nursing and Health StudiesAuthor(s): Alanood Kateb Kalef Alruwaily
Diversity & Equality in Health and CareAuthor(s): Tracy Roake, Aiza Munoz
Journal of Nursing and Health StudiesAuthor(s): SAMEER JOSHI
Journal of Environmental ResearchAuthor(s): Paul A Comet
Journal of Environmental ResearchAuthor(s): Dr Alirio Martinho Belchior
Journal of Nursing and Health StudiesAuthor(s): Marianne Allen
Diversity & Equality in Health and CareAuthor(s): Ebede S1, Nwafia I1* , Ohanu M1, Ozumba U1, Chukwuka C2 and Onyedum C2
Archives of Clinical MicrobiologyAuthor(s): Susana Aaron*
Archives of Clinical MicrobiologyAuthor(s): Vinay Kumar
American Journal of Phytomedicine and Clinical TherapeuticsAuthor(s): Susana Aaron*
Archives of Clinical MicrobiologyAuthor(s): Vinay Kumar
American Journal of Phytomedicine and Clinical TherapeuticsAuthor(s): Vinay Kumar
American Journal of Phytomedicine and Clinical TherapeuticsAuthor(s): Ali Kabir*
Medical & Clinical ReviewsAuthor(s): Ali Kabir*
Medical & Clinical ReviewsAuthor(s): Ahmar Shamim*
Medical & Clinical ReviewsAuthor(s): Lucia Kiio* , Damaris Mbui and Peter Ndangili
Medical & Clinical ReviewsAuthor(s): Meena Gupta* and Divya Pandey
Medical & Clinical ReviewsAuthor(s): US Food and Drug Administration (FDA) exercises flexibility in the requirement that new drugs provide substantial evidence of benefit under the Food, Drug and Cosmetic Act. Provisions in law and policy provide numerous exceptions to the historical scientific standard of 2 or more controlled clinical trials demonstrating statistically significant evidence of benefit.
Journal of Pharmacy and Pharmaceutical Research